Participated · Series B · Jul 2025

Numan is a UK digital healthtech company that delivers personalised, integrated care on a single platform, including clinical guidance, medication, behavioural health coaching, diagnostics and supplements. It focuses on stigmatised conditions such as obesity and testosterone deficiency and has treated over 650,000 patients across obesity management, men’s health, and diagnostics. Numan reported $90M in 2024 revenue, saw revenue more than double year-on-year, achieved profitability 18 months ago, and maintains a market-leading NPS of 68. The company plans to expand into female health and deepen patient relationships through enhanced screening and preventive care programmes. Funding will also support scaling the platform’s infrastructure, expanding marketing to reach more patients, and advancing AI-driven capabilities in a clinically responsible manner. Leadership frames the raise as a move to scale what works after strong commercial performance and high patient engagement. Numan operates a subscription service addressing men’s health issues including hair loss, gut and lung health, sexual health, and nutritional deficiencies. Its product set includes an AI-powered symptom checker, online access to medical professionals, prescription medication, at-home blood testing, and consumer health products. The company has recently launched its blood testing proposition in the UK and acquired Swedish medical science and healthcare technology company Vi-Health last year. Numan says it has grown revenues by almost three times year-on-year. It plans to launch new therapeutic areas in men’s health, expand internationally, and aims to double its headcount in 2022. The firm positions itself as a consumer health brand for men in Europe. Numan offers a subscription-based digital healthcare service for men, covering erectile dysfunction, premature ejaculation, hair loss, gut and lung health, and nutritional deficiencies. The company enables remote testing, including blood tests that do not require in-person appointments. Post-pandemic demand for remote health and behavioral support has accelerated adoption of Numan’s model. Numan is regulated by the Care Quality Commission as a registered healthcare provider. The company has expanded both organically and via two strategic acquisitions in the U.K. and Sweden to broaden its footprint. In an internal survey of 800 subscribers, 88% said Numan improved their confidence and 68% said it improved their relationships, while over half reported the pandemic gave them a more positive impression of digital healthcare. Launched almost 18 months ago, Numan joined a growing set of sites targeting men’s health. It began by promoting accessible medical remedies for erectile dysfunction and has since expanded into other areas, building a brand around pharmaceuticals on subscription. The company positions itself as providing simple and accessible solutions for men’s health and wellbeing. Numan closed a £10 million Series A to support its growth. It plans to use the funds to continue investing in technology, expand operations and grow the team. Sam Shah, former CEO of NHSX, recently joined Numan as chief medical strategy officer, and Birgir Már Ragnarsson of Novator will join the board.

Led · Equity · May 2024

Steel City Interactive is a developer and operator of boxing games. The company developed the boxing title "Undisputed." DoNews reported that Steel City Interactive recently raised more than £15 million in a financing round. The article described the funding as a strategic investment led by Novator Ventures. No other financial details, instruments, or operating metrics were disclosed in the article. The report was published on May 14, 2024.

Participated · Equity · Sep 2023

Nord Security develops internet privacy and security products, including consumer VPN NordVPN, password manager NordPass, business network access product NordLayer, and encrypted cloud storage NordLocker. The company was co-founded in Lithuania in 2012 and is now based in Amsterdam. It operates in more than 20 markets and employs around 2,000 professionals globally. Nord Security says it has built a diversified revenue stream and a global user base after more than a decade of being bootstrapped. The company intends to use the new funds to expand its product offering and accelerate growth through strategic mergers and acquisitions. The recent financing values the company at $3 billion. Nord Security offers consumer VPN services and a suite of related products including NordPass (password manager), NordLocker (cloud sync/storage) and NordLayer (network access for businesses). The company reports about 15 million users across its consumer and enterprise products. Founded in 2012 in Vilnius, Lithuania, Nord was bootstrapped for ten years and has amassed roughly 100 patents. Its strategy combines organic product development and M&A, including a February merger with Surfshark, and it plans to further build out both consumer and enterprise business lines. Nord has faced security and regulatory challenges — a data-center breach that the company says did not result in compromised data, criticism of browser extensions, and pressure from Russia that prompted it to pull business from the country — and has since reconfigured systems to be diskless, expanded internal security teams and undergone regular audits with Versprite. The company is positioning its paid offerings for scale while emphasizing its mission to protect user privacy and networks.

Participated · Series C · Jul 2022

Klang Games is a game studio focused on exploring the future of humanity through various media, anchored by SEED, a large-scale virtual world experienced via AI-driven virtual humans called Seedlings. SEED is set in the world of Avesta and offers a player-driven economy, self-governance, customizable Seedlings, and community-oriented gameplay that relies on player caretaking. The title is currently in pre-alpha and emphasizes creating an online space where people can connect, work together, and build strong communities. With the new funding, the company plans to accelerate SEED’s development, further develop its scalable back-end and technical infrastructure, and double headcount from about 70 to 150 within 12 months while creating a collaborative workplace in central Berlin. Klang Games completed a $41M Series C that brings its total funding to nearly $80M. Founded in 2013 and led by CEO Mundi Vondi, the company also added Isabelle Henriques as Co-CEO and COO in February 2022. Klang Games is an independent, Berlin-based game development studio led by CEO Mundi Vondi. The studio launched its first project, ReRunners: Race for the World, for iOS and Android devices in July 2015. It is now developing Seed, a simulation MMO that utilizes SpatialOS technology to enable small teams to build massive simulations. Klang Games raised $8.95m in funding in the reported round. The company has raised $13.95m to date and will use the new funds to support development of Seed. Klang Games is a Berlin-based independent game studio founded in 2013 by Ívar Emilsson and Oddur Magnússon, together with artist Mundi Vondi. The studio is developing its first title, ReRunners, a mobile and tablet online asynchronous multiplayer with an open world and fast-paced racing gameplay. ReRunners is in beta and slated to launch in New Zealand, Australia, and the Philippines in the coming weeks, with a global launch planned for October. Klang emphasizes maintaining independent roots and creative control, focusing on accessible, social gameplay that builds player communities. The founders collectively bring about 15 years’ experience developing online-multiplayer games from work at CCP Games (EVE Online, Dust 514). London Venture Partners will provide financial support and publishing expertise as part of the partnership.

Led · Series B · May 2022

Sidekick Health has built a gamified digital care platform that delivers personalized behavioral lifestyle nudges and digital therapeutics to support patients with chronic conditions (cancer, cardiovascular disease, diabetes, arthritis and others), and to augment drug treatments. The company operates as a B2B vendor targeting payers and pharma, with partnerships including Anthem, Bayer and Pfizer. Its platform has helped more than 40,000 patients globally and is available in six languages; its largest markets are Europe and the U.S., and it has offices in the U.S., Germany, Sweden and Iceland. Sidekick says it grew revenue threefold in 2021 and plans to use new funding to expand its U.S. commercial footprint while doubling headcount from about 120 to 240. The firm intends to build a portfolio of more than 40 medical-grade digital therapeutics by 2026 (18 in R&D today) and currently has 14 commercial partnerships. It emphasizes life-science–grade evidence generation and has published feasibility and randomized trials across several indications. Sidekick Health operates a gamified digital care platform that uses a helmet-wearing cartoon helper to deliver digital nudges, medication reminders and remote patient monitoring for clinicians. The platform provides evidence-based, custom digital therapeutics packages across multiple therapeutic areas including diabetes, ulcerative colitis and smoking cessation, and has been adapted for COVID-19 support. It operates a b2b2c model, partnering with pharma and healthcare providers (notably Pfizer and Bayer) to reach patients; the platform currently reaches around 30,000 patients via those customers. The company emphasizes clinical validation and has published a randomized controlled trial in type 2 diabetes showing significant drops in average blood glucose with associated risk reductions. Sidekick plans to expand into heart failure, oncology and metabolic conditions and aims within two years to address over 20 chronic (and some acute) illnesses. The business is prioritizing growth over profitability and is investing the Series A proceeds into product expansion, accelerated market growth in Europe and the US, and expanded medical and science operations. Goodlifeme has developed SidekickHealth, a gamified platform and app that uses behavioral economics and artificial intelligence alongside evidence-based CDC guidelines to predict, manage and prevent chronic and lifestyle-related conditions such as obesity, heart disease, prediabetes and type-2 diabetes. The platform is designed to enhance the effectiveness of lifestyle education and coaching, including programs such as the CDC’s Diabetes Prevention Program. SidekickHealth has been developed and researched in collaboration with experts from institutions including Harvard University and the Massachusetts Institute of Technology. The app has recently gained traction in the U.S., Iceland, and Sweden. The company is led by founders Tryggvi “Thor” Thorgeirsson, M.D., M.P.H., and Sæmundur “Sam” Oddsson, M.D. Financially, the company announced a $1.5M funding round in early 2017.